These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29401079)

  • 1. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
    Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
    Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
    Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
    Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index.
    Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH
    Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
    Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
    Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of alfentanil target-controlled infusion in normal and morbidly obese female patients.
    Pérus O; Marsot A; Ramain E; Dahman M; Paci A; Raucoules-Aimé M; Simon N
    Br J Anaesth; 2012 Oct; 109(4):551-60. PubMed ID: 22732112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive pharmacodynamic performance of the Eleveld pharmacokinetic-pharmacodynamic model for propofol: comparison of predicted and measured bispectral index.
    Coetzee E; Coetzee JF; Haasbroek M
    Br J Anaesth; 2024 Oct; 133(4):785-792. PubMed ID: 39179443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
    Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
    Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.
    Chidambaran V; Venkatasubramanian R; Sadhasivam S; Esslinger H; Cox S; Diepstraten J; Fukuda T; Inge T; Knibbe CAJ; Vinks AA
    Paediatr Anaesth; 2015 Sep; 25(9):911-923. PubMed ID: 25975390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints.
    Blussé van Oud-Alblas HJ; Brill MJE; Peeters MYM; Tibboel D; Danhof M; Knibbe CAJ
    BMC Anesthesiol; 2019 Jan; 19(1):15. PubMed ID: 30669968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.
    Coetzee JF
    Clin Pharmacokinet; 2012 Mar; 51(3):137-45. PubMed ID: 22316280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.
    Dahaba AA; Xiao Z; Zhu X; Dong H; Xiong L; Rehak P; Zelzer S; Wang K; Reibnegger G
    J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):145-161. PubMed ID: 32100175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Propofol Target Concentrations, Bispectral Index, and Patient Covariates During Anesthesia.
    Schnider TW; Minto CF; Egan TD; Filipovic M
    Anesth Analg; 2021 Mar; 132(3):735-742. PubMed ID: 32833715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cardiovascular depression effect for propofol during anesthesia induction period on morbidly obese patients.
    Wu Z; Li J; Wang C; Yang J; Chen X; Yang W; Xiong Z; Peng X
    Biomed Pharmacother; 2018 Oct; 106():618-623. PubMed ID: 29990851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of TCI Propofol Using the Schnider Model for Cardiac Surgery on Cardiopulmonary Bypass-A Pilot Study.
    Lee AKY; Kong AYH; Kong CF
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):723-730. PubMed ID: 29225156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia.
    Mertens MJ; Engbers FH; Burm AG; Vuyk J
    Br J Anaesth; 2003 Feb; 90(2):132-41. PubMed ID: 12538367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
    Eleveld DJ; Colin P; Absalom AR; Struys MMRF
    Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Bayesian optimization on the performance of propofol target-controlled infusion.
    van den Berg JP; Eleveld DJ; De Smet T; van den Heerik AVM; van Amsterdam K; Lichtenbelt BJ; Scheeren TWL; Absalom AR; Struys MMRF
    Br J Anaesth; 2017 Nov; 119(5):918-927. PubMed ID: 29028925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery.
    Przybyłowski K; Tyczka J; Szczesny D; Bienert A; Wiczling P; Kut K; Plenzler E; Kaliszan R; Grześkowiak E
    J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):111-22. PubMed ID: 25628234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of propofol pharmacokinetic and pharmacodynamic models for awake craniotomy: A prospective observational study.
    Soehle M; Wolf CF; Priston MJ; Neuloh G; Bien CG; Hoeft A; Ellerkmann RK
    Eur J Anaesthesiol; 2015 Aug; 32(8):527-34. PubMed ID: 25774459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target-Controlled Infusions Could Improve the Safety and Efficacy of Emergency Department Propofol Sedation.
    Green SM; Krauss BS
    Anesth Analg; 2016 Jan; 122(1):283-4. PubMed ID: 26678474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.